Fasano, Alfonso
 Distribuzione geografica
Continente #
EU - Europa 3.158
NA - Nord America 2.709
AS - Asia 857
AF - Africa 29
OC - Oceania 14
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.779
Nazione #
US - Stati Uniti d'America 2.692
DE - Germania 1.256
SE - Svezia 513
CN - Cina 431
UA - Ucraina 333
IT - Italia 246
FR - Francia 201
SG - Singapore 175
IE - Irlanda 162
GB - Regno Unito 156
ID - Indonesia 86
FI - Finlandia 83
IN - India 76
RU - Federazione Russa 71
PL - Polonia 60
TR - Turchia 26
CI - Costa d'Avorio 21
JP - Giappone 20
NL - Olanda 19
BE - Belgio 14
AU - Australia 13
IR - Iran 13
CA - Canada 10
HK - Hong Kong 9
ES - Italia 8
MX - Messico 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BG - Bulgaria 5
RO - Romania 5
CH - Svizzera 4
EU - Europa 4
IL - Israele 4
KE - Kenya 4
BR - Brasile 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
VN - Vietnam 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
PT - Portogallo 2
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.779
Città #
Chandler 589
Ashburn 215
Jacksonville 170
Dublin 159
San Mateo 145
Singapore 121
Nanjing 97
Wilmington 93
Jakarta 86
Ann Arbor 79
New York 75
Nürnberg 75
Dearborn 70
Woodbridge 65
Boston 62
Lawrence 58
Warsaw 56
Houston 54
Seattle 48
Fairfield 46
Milan 45
Lancaster 42
Marseille 42
Beijing 41
Nanchang 38
Redwood City 35
Cattolica 33
Moscow 32
Munich 28
Redmond 27
University Park 26
Mountain View 25
Norwalk 24
Princeton 24
Bremen 22
Izmir 22
Jiaxing 22
Shenyang 22
Abidjan 21
Rome 21
Leawood 20
Changsha 18
Hangzhou 17
Hebei 17
Boardman 16
Brussels 14
Los Angeles 14
Shanghai 14
Tianjin 14
Fremont 13
Pune 13
Cambridge 12
Lappeenranta 12
London 12
Simi Valley 12
Kunming 11
Zhengzhou 11
Chicago 10
Augusta 9
Poitiers 9
Falls Church 7
Phoenix 7
Amsterdam 6
Columbus 6
Detroit 6
Guangzhou 6
Fort Worth 5
Fuzhou 5
Helsinki 5
Lanzhou 5
Taizhou 5
Tehran 5
Toronto 5
Vienna 5
Brisbane 4
Bronxville 4
Chelmsford 4
Chennai 4
Costa Mesa 4
Dubai 4
Hong Kong 4
Jinan 4
Locarno 4
Andover 3
Berlin 3
Castelfidardo 3
Central 3
Chengdu 3
Cologne 3
Edinburgh 3
Gergei 3
Hefei 3
Mexico 3
Padova 3
Philadelphia 3
São Paulo 3
Tappahannock 3
Tokyo 3
Ardabil 2
Athens 2
Totale 3.386
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 196
The role of small intestinal bacterial overgrowth in Parkinson's disease 179
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 142
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 136
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 135
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 127
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 126
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 123
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 120
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 116
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 115
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 113
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 111
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 110
Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year 109
Movement disorders in multiple sclerosis: Causal or coincidental association? 104
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 103
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 100
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 99
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 99
Dystonia gravidarum: a new case with a long follow-up 98
Analysis of blink rate in patients with blepharospasm 98
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 98
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 96
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 93
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 91
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 90
Homotoxicology remedies versu desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. 89
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 89
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 89
Tourettism in multiple sclerosis: a case report 89
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 89
Reliability of Clinical Diagnosis of Dystonia 89
New olfactometric findings in Parkinson's disease 89
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 88
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 88
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 87
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 87
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 87
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 86
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 86
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 86
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 85
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 80
Management of status dystonicus: our experience and review of the literature 80
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 80
The long-term effect of tetrabenazine in the management of Huntington disease 79
Punding and computer addiction in Parkinson's disease 77
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 77
RARE AND SERIOS CARDIAC SIDE EFFECTS DURING ROPINIROLE TITRATION 75
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 75
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 75
Acute necrotizing encephalopathy: a relapsing case in a European adult 73
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 73
Humanitarian mission improves health conditions of schoolchildren in Ethiopia. the case of Adwa 72
Onset and progression of primary torsion dystonia in sporadic and familial cases 71
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 67
Rare and serious cardiac side effects during ropinirole titration 67
Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis 67
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 66
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 65
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 65
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 65
Movement disorders phenomenology in focal motor seizures 61
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion 56
Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: The Centro per la Lotta Contro L'infarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE study 56
Status dystonicus: predictors of outcome and progression patterns of underlying disease 55
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life 54
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 54
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 52
Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome 51
Punding (PD) 50
Role of optical coherence tomography for distal left main stem angioplasty 46
Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study 46
Treatment of dystonia using trihexyphenidyl in costello syndrome 46
Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story 42
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 42
Pisa syndrome in Parkinson disease 42
Tetrabenazine 41
Implementation of the Current Dystonia Classification from 2013 to 2018 39
Psychogenic facial movement disorders: Clinical features and associated conditions 34
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials 15
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease? 8
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. 3
Totale 6.872
Categoria #
all - tutte 26.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020661 0 0 0 59 50 82 89 51 55 59 118 98
2020/2021801 61 83 10 75 94 33 75 27 104 81 143 15
2021/2022810 67 81 20 45 46 26 21 126 35 69 118 156
2022/20231.606 190 217 123 232 118 202 83 145 194 21 59 22
2023/2024718 39 215 21 31 13 110 38 36 11 34 101 69
2024/2025230 23 49 124 34 0 0 0 0 0 0 0 0
Totale 6.872